Trinity Biotech (TRIB) Long-Term Investments (2019 - 2025)
Trinity Biotech (TRIB) posted Long-Term Investments of $2.8 million for Q4 2025, up 12.95% sequentially from $2.5 million in Q4 2024, and up 12.95% YoY from $2.5 million in Q4 2024.
Trinity Biotech (TRIB) Long-Term Investments (2019 - 2025) Analysis & Trends
Trinity Biotech has reported Long-Term Investments for 7 years, with the latest figure at $2.8 million in Q4 2025.
- Quarterly Long-Term Investments rose 12.95% year-over-year to $2.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.8 million (up 12.95% YoY) and the FY2025 annual result came in at $2.8 million, up 12.95% from the prior year.
- Long-Term Investments improved to $2.8 million in Q4 2025 per TRIB's latest filing, from $2.5 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $21.8 million in Q4 2021 and troughed at $2.5 million in Q4 2024.
- A 5-year average of $7.6 million and a median of $4.9 million in 2023 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2022 and 2025: Long-Term Investments slumped 72.37% in 2022, then climbed 12.95% in 2025.
- Over 5 years, Long-Term Investments stood at $21.8 million in 2021, then plunged by 72.37% to $6.0 million in 2022, then retreated by 18.79% to $4.9 million in 2023, then tumbled by 49.84% to $2.5 million in 2024, then gained by 12.95% to $2.8 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $2.8 million, $2.5 million, and $4.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - | 25.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 6.03 Mn |
| Dec 31, 2021 | 21.81 Mn |
| Dec 31, 2020 | 19.94 Mn |
| Dec 31, 2019 | 18.73 Mn |